Persistent URL of this record https://hdl.handle.net/1887/75048
Documents
-
- Download
- mdx753
- Not Applicable (or Unknown)
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
- All authors
- Boer, S.M. de; Wortman, B.G.; Bosse, T.; Powell, M.E.; Singh, N.; Hollema, H.; Wilson, G.; Chowdhury, M.N.; Mileshkin, L.; Pyman, J.; Katsaros, D.; Carinelli, S.; Fyles, A.; McLachlin, C.M.; Haie-Meder, C.; Duvillard, P.; Nout, R.A.; Verhoeven-Adema, K.W.; Putter, H.; Creutzberg, C.L.; Smit, V.T.H.B.M.; PORTEC Study Grp
- Date
- 2018-02-28
- Journal
- Annals of Oncology
- Volume
- 29
- Issue
- 2
- Pages
- 424 - 430